Area of research
Cardiology and Cardiovascular Medicine · Internal Medicine
Research interest
Research interests include Atrial Fibrillation Management and Outcomes, Venous Thromboembolism Diagnosis and Management, Antiplatelet Therapy and Cardiovascular Diseases, and Blood Coagulation and Thrombosis Mechanisms.
<scp>ISUOG</scp>/<scp>ESGO</scp> Consensus Statement on ultrasound‐guided biopsy in gynecological oncology
Management of Bleeding and Hemolysis During Percutaneous Microaxial Flow Pump Support
Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis
Cardiovascular risk of metabolically healthy obesity in two european populations: Prevention potential from a metabolomic study
The Relevance of Arterial Blood Pressure in the Management of Glaucoma Progression: A Systematic Review
Clinical application of multigene panel testing for bleeding, thrombotic, and platelet disorders: a 3-year Belgian experience
Heparin dosing in patients with Impella-supported cardiogenic shock
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial
Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock
Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism
Neutrophils Protect Against <i>Staphylococcus aureus</i> Endocarditis Progression Independent of Extracellular Trap Release
Prevalence of Acute Pulmonary Embolism at Autopsy in Patients With COVID-19
Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization
Tranexamic acid for the prevention and treatment of bleeding in surgery, trauma and bleeding disorders: a narrative review
Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score
Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis
Isolated Diastolic Hypertension in the IDACO Study: An Age-Stratified Analysis Using 24-Hour Ambulatory Blood Pressure Measurements
Coagulation: At the heart of infective endocarditis
Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure
Cardiovascular End Points and Mortality Are Not Closer Associated With Central Than Peripheral Pulsatile Blood Pressure Components
Association of Fatal and Nonfatal Cardiovascular Outcomes With 24-Hour Mean Arterial Pressure
Why we need safer anticoagulant strategies for patients on short-term percutaneous mechanical circulatory support
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant
<i>Staphylococcus aureus</i> endocarditis: distinct mechanisms of bacterial adhesion to damaged and inflamed heart valves
Interplay of cardiac remodelling and myocardial stiffness in hypertensive heart disease: a shear wave imaging study using high-frame rate echocardiography
Von Willebrand factor and ADAMTS13 impact on the outcome of Staphylococcus aureus sepsis
Relation of Insulin Resistance to Longitudinal Changes in Left Ventricular Structure and Function in a General Population